Enterome and Nestlé Health Science will co-develop Enterome's lead EndoMimics compound, EB1010, a potent local inducer of IL-10 targeting food allergies and inflammatory bowel disease (IBD).
Enterome highlights Microbiome publication describing sibofimloc s novel mechanism of action for the treatment of Crohn s disease prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.